TUBA1C and neoplasm: Previous studies have shown that TUBA1C can predict poor outcome in PDAC [6] by modulating cell cycle signalling pathways to induce apoptosis, in LUAD [5] and LGG [11] by affecting TIICs in the tumour microenvironment, and in HCC [7] by cell cycle signalling pathways.